ABX:TSXBarrick Mining Corporation Analysis
Data as of 2026-03-10 - not real-time
CA$62.27
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Barrick Mining Corp. (ABX) trades at C$62.27, well below its DCF‑derived fair value of C$92.21, implying roughly a 30% upside potential. The stock sits just above the 20‑day SMA (C$65.26) and the 50‑day SMA (C$65.67), while the 200‑day SMA (C$46.60) remains far lower, indicating a neutral short‑term bias but a long‑term uptrend. Technicals show a modestly bearish MACD (‑0.52 vs signal +0.11) and an RSI of 42, suggesting limited momentum but no oversold condition. Volume is increasing and volatility is high at 61% over the past 30 days, yet beta is low (0.47), cushioning market‑wide swings. Fundamentally, revenue surged 64.5% YoY to C$16.96 bn, with strong operating (52.6%) and profit margins (29.4%). The company generates robust cash flow (C$7.69 bn operating, C$4.05 bn free) and holds more cash than debt, supporting its 3.72% dividend yield and a modest 18% payout ratio. Recent leadership appointments and the resolution of the Mali dispute enhance governance and geopolitical stability. Analyst consensus (11 analysts) rates the stock as a “buy” with a target median of C$80.21, reinforcing the valuation case. Overall, the blend of undervaluation, solid growth, and sustainable dividends makes ABX attractive across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price below DCF fair value with ~30% upside
- Increasing volume and strong cash position
- Technical support near C$58.48
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained revenue growth (64.5%) and high margins
- Stable dividend yield (3.72%) with low payout
- Analyst consensus buy and target median C$80.21
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term uptrend indicated by 200‑day SMA
- Strong balance sheet (cash > debt) and low beta
- Strategic leadership hires and resolved geopolitical disputes
Key Metrics & Analysis
Financial Health
Revenue Growth64.50%
Profit Margin29.45%
P/E Ratio15.4
ROE20.68%
ROA9.97%
Debt/Equity14.51
P/B Ratio2.9
Op. Cash FlowCA$7.7B
Free Cash FlowCA$4.1B
Technical Analysis
TrendNeutral
RSI42.2
SupportCA$58.48
ResistanceCA$70.05
MA 20CA$65.26
MA 50CA$65.67
MA 200CA$46.60
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair ValueCA$92.21
Target PriceCA$80.70
Upside/Downside29.59%
GradeUndervalued
TypeBlend
Dividend Yield3.72%
Risk Assessment
Beta0.47
Volatility61.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.